Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Roquefort Investments PLC ( (GB:ROQ) ) just unveiled an update.
Roquefort Therapeutics PLC announced that all resolutions proposed at their Annual General Meeting were passed. The resolutions were voted on by shareholders via a poll, with a significant majority supporting each resolution. This outcome reflects strong shareholder confidence in the company’s strategic direction and its focus on developing innovative treatments in the biotech sector.
More about Roquefort Investments PLC
Roquefort Therapeutics PLC is a biotech company listed on the Main Market, focusing on developing first-in-class medicines in the high-value and high-growth immunology and oncology markets. The company has a portfolio of five novel patent-protected pre-clinical anti-cancer and immunology assets.
Average Trading Volume: 1,127,597
Technical Sentiment Signal: Sell
Current Market Cap: £2.13M
For a thorough assessment of ROQ stock, go to TipRanks’ Stock Analysis page.